Rockwell Medical: The Turnaround Is Looking Real

Dobri Dobrev/E+ via Getty Images Investment Thesis After a few complicated years with revenue that didn't grow as much, a gross margin that was even negative and numerous changes in CEOs, Mr. Mark Strobeck arrived at Rockwell Medical (NASDAQ:RMTI) in 2022 to completely turn around the situation and currently it has even reached the first quarter net income profitable, something unthinkable a few years ago. If the expectation is met and the gross margin expands to 25% from now to 2028 (the expectation is tha ...